Can mailing buprenorphine keep people in recovery?

NCT ID NCT07421102

Recruiting now Disease control Sponsor: Medical University of South Carolina Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 31, 2026 · Updated 3 times

Summary

This pilot study is testing whether mailing buprenorphine to people with opioid use disorder after a hospital stay can help them stay in treatment. The goal is to overcome common barriers like lack of transportation or trouble getting to a pharmacy. Researchers will track whether the medication is received and if participants remain in treatment for up to six months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: buprenorphine
What this could lead to: If successful, this approach could make it easier for people with opioid use disorder to stay on treatment after leaving the hospital, especially those with transportation or pharmacy access issues.
What could go wrong: This is a very small early-phase study with only 20 participants, so results may not apply to everyone. Mailing a controlled substance also raises safety and delivery concerns.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPIOID-USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

opiate dependence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OPIOID-USE DISORDER

Contacts and locations

Locations

Medical University of South Carolina
NOT_YET_RECRUITING

Charleston, South Carolina, 29425, United States
Medical University of South Carolina
RECRUITING

Charleston, South Carolina, 29425, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.